Sodium pentosan polysulfate efficacy as thromboprophylaxis agent in high-risk women following gynecological surgery

2018 ◽  
Vol 44 (8) ◽  
pp. 1458-1465
Author(s):  
Ima Indirayani ◽  
Aida Kalok ◽  
Nik A. Nik Ismail ◽  
Shamsul A. Shah ◽  
Pei S. Lim ◽  
...  
Keyword(s):  
High Risk ◽  
Gynecological Surgery ◽  
Pentosan Polysulfate ◽  
High Risk Women ◽  
Sodium Pentosan Polysulfate

Microbicide Acceptability To Prevent HIV In High-Risk Women

2002 ◽  
Author(s):  
Margaret R. Weeks ◽  
Jean J. Schensul ◽  
Laurie Novick Sylla
Keyword(s):  
High Risk ◽  
High Risk Women ◽  
Microbicide Acceptability

TVS & endometrial sampling and thin prep technique as screening test for endometrial lesions and cancer in high risk women

2007 ◽  
Vol 28 (S 1) ◽  
Author(s):  
A Koutras ◽  
K Salampasis ◽  
N Euaggelinakis ◽  
H Polyzou ◽  
D Dellaporta ◽  
...  
Keyword(s):  
High Risk ◽  
Screening Test ◽  
Endometrial Sampling ◽  
High Risk Women

scholarly journals Understanding low chemoprevention uptake by women at high risk of breast cancer: findings from a qualitative inductive study of women’s risk-reduction experiences

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Tasleem J. Padamsee ◽  
Megan Hils ◽  
Anna Muraveva
Keyword(s):  
Breast Cancer ◽  
African American ◽  
High Risk ◽  
Risk Reduction ◽  
White Women ◽  
Future Research ◽  
Structured Interviews ◽  
Critical Gap ◽  
High Risk Women ◽  
Parent Project

Abstract Background Chemoprevention is one of several methods that have been developed to help high-risk women reduce their risk of breast cancer. Reasons for the low uptake of chemoprevention are poorly understood. This paper seeks a deeper understanding of this phenomenon by drawing on women’s own narratives about their awareness of chemoprevention and their risk-related experiences. Methods This research is based on a parent project that included fifty in-depth, semi-structured interviews with a purposive sample of African American and White women at elevated risk of breast cancer. This specific study draws on the forty-seven interviews conducted with women at high or severe risk of breast cancer, all of whom are eligible to use chemoprevention for breast cancer risk-reduction. Interviews were analyzed using grounded theory methods. Results Forty-five percent of participants, and only 21% of African American participants, were aware of chemoprevention options. Women who had seen specialists were more likely to be aware, particularly if they had ongoing specialist access. Aware and unaware women relied on different types of sources for prevention-related information. Those whose main source of information was a healthcare provider were more likely to know about chemoprevention. Aware women used more nuanced information gathering strategies and worried more about cancer. Women simultaneously considered all risk-reduction options they knew about. Those who knew about chemoprevention but were reluctant to use it felt this way for multiple reasons, having to do with potential side effects, perceived extreme-ness of the intervention, similarity to chemotherapy, unknown information about chemoprevention, and reluctance to take medications in general. Conclusions Lack of chemoprevention awareness is a critical gap in women’s ability to make health-protective choices. Future research in this field must consider complexities in both women’s perspectives on chemoprevention and the reasons they are reluctant to use it.

Sign in / Sign up

Export Citation Format

Share Document